Maria Tengström

3.5k total citations
20 papers, 385 citations indexed

About

Maria Tengström is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Maria Tengström has authored 20 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Cancer Research and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Maria Tengström's work include DNA Repair Mechanisms (5 papers), Genetic factors in colorectal cancer (5 papers) and Cancer Genomics and Diagnostics (5 papers). Maria Tengström is often cited by papers focused on DNA Repair Mechanisms (5 papers), Genetic factors in colorectal cancer (5 papers) and Cancer Genomics and Diagnostics (5 papers). Maria Tengström collaborates with scholars based in Finland, Sweden and Denmark. Maria Tengström's co-authors include Veli‐Matti Kosma, Jaana M. Hartikainen, Ylermi Soini, Arto Mannermaa, Hamid Behravan, Robert Winqvist, Katri Pylkäs, Vesa Kataja, Vuokko L. Kinnula and B Berdel and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Maria Tengström

19 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Tengström Finland 12 254 99 72 71 33 20 385
Tonje G. Lien Norway 9 260 1.0× 119 1.2× 48 0.7× 72 1.0× 38 1.2× 15 378
Diogo Ferreira da Costa Patrão Brazil 8 252 1.0× 118 1.2× 36 0.5× 94 1.3× 30 0.9× 17 378
Eleftherios Pilalis Greece 10 257 1.0× 64 0.6× 39 0.5× 46 0.6× 43 1.3× 28 381
Hui‐Min Lin United States 8 211 0.8× 108 1.1× 36 0.5× 82 1.2× 19 0.6× 13 385
Huiting Dong China 12 199 0.8× 129 1.3× 87 1.2× 160 2.3× 37 1.1× 18 455
Yiran Tao China 9 199 0.8× 98 1.0× 44 0.6× 73 1.0× 34 1.0× 17 328
Lora Ziyabari United States 3 220 0.9× 75 0.8× 122 1.7× 28 0.4× 24 0.7× 4 350
Yangzhige He China 10 288 1.1× 97 1.0× 53 0.7× 104 1.5× 37 1.1× 21 527

Countries citing papers authored by Maria Tengström

Since Specialization
Citations

This map shows the geographic impact of Maria Tengström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Tengström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Tengström more than expected).

Fields of papers citing papers by Maria Tengström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Tengström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Tengström. The network helps show where Maria Tengström may publish in the future.

Co-authorship network of co-authors of Maria Tengström

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Tengström. A scholar is included among the top collaborators of Maria Tengström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Tengström. Maria Tengström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mali, Pekka, Anu Anttonen, Kaisa Lehtiö, et al.. (2025). Changes in the use of chemoradiotherapy for non-small cell lung cancer after guideline implementation in Finland between 2016 and 2020. Cancer Treatment and Research Communications. 45. 100996–100996. 1 indexed citations
3.
Tengström, Maria, et al.. (2024). Circulating Micro-RNAs Predict the Risk of Recurrence in Triple-Negative Breast Cancer. Cells. 13(22). 1884–1884. 4 indexed citations
5.
Hartikainen, Jaana M., Maria Tengström, Reijo Sironen, et al.. (2022). Circulating Cell-Free DNA Reflects the Clonal Evolution of Breast Cancer Tumors. Cancers. 14(5). 1332–1332. 9 indexed citations
6.
Tengström, Maria, et al.. (2021). High Cell-Free DNA Integrity Is Associated with Poor Breast Cancer Survival. Cancers. 13(18). 4679–4679. 9 indexed citations
7.
Heikkinen, Sami, et al.. (2021). The debatable presence of PIWI‐interacting RNAs in invasive breast cancer. Cancer Medicine. 10(11). 3593–3603. 15 indexed citations
8.
Hartikainen, Jaana M., et al.. (2020). High mutation burden of circulating cell‐free DNA in early‐stage breast cancer patients is associated with a poor relapse‐free survival. Cancer Medicine. 9(16). 5922–5931. 11 indexed citations
9.
Behravan, Hamid, et al.. (2020). Predicting breast cancer risk using interacting genetic and demographic factors and machine learning. Scientific Reports. 10(1). 11044–11044. 43 indexed citations
10.
Behravan, Hamid, Jaana M. Hartikainen, Maria Tengström, et al.. (2018). Machine learning identifies interacting genetic variants contributing to breast cancer risk: A case study in Finnish cases and controls. Scientific Reports. 8(1). 13149–13149. 46 indexed citations
11.
Kiiski, Johanna I., Liisa M. Pelttari, Sofia Khan, et al.. (2017). FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population. Breast Cancer Research and Treatment. 166(1). 217–226. 22 indexed citations
12.
Kiiski, Johanna I., Rainer Fagerholm, Liisa M. Pelttari, et al.. (2016). FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome. International Journal of Cancer. 139(12). 2760–2770. 9 indexed citations
13.
Hartikainen, Jaana M., Maria Tengström, Robert Winqvist, et al.. (2015). KEAP1 Genetic Polymorphisms Associate with Breast Cancer Risk and Survival Outcomes. Clinical Cancer Research. 21(7). 1591–1601. 39 indexed citations
14.
Tengström, Maria, et al.. (2015). Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival. BMC Cancer. 15(1). 431–431. 26 indexed citations
15.
Tengström, Maria, et al.. (2014). MnSODrs4880 andXPDrs13181 polymorphisms predict the survival of breast cancer patients treated with adjuvant tamoxifen. Acta Oncologica. 53(6). 769–775. 11 indexed citations
16.
Tengström, Maria, et al.. (2014). XRCC1 rs25487 polymorphism predicts the survival of patients after postoperative radiotherapy and adjuvant chemotherapy for breast cancer.. PubMed. 34(6). 3031–7. 12 indexed citations
17.
Hartikainen, Jaana M., et al.. (2014). Type II Transmembrane Serine Protease Gene Variants Associate with Breast Cancer. PLoS ONE. 9(7). e102519–e102519. 20 indexed citations
18.
Hartikainen, Jaana M., Maria Tengström, Veli‐Matti Kosma, et al.. (2012). Genetic Polymorphisms and Protein Expression of NRF2 and Sulfiredoxin Predict Survival Outcomes in Breast Cancer. Cancer Research. 72(21). 5537–5546. 65 indexed citations
19.
Tengström, Maria, et al.. (2012). SULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer?. BMC Cancer. 12(1). 257–257. 10 indexed citations
20.
Berdel, B, Kaisa Nieminen, Ylermi Soini, et al.. (2012). Histone demethylase GASC1 - a potential prognostic and predictive marker in invasive breast cancer. BMC Cancer. 12(1). 516–516. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026